Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report By Type (Medical Device Analytical Testing Services, Pharmaceutical Analytical Testing Services), By Region, And Segment Forecasts, 2024 - 2030

Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report By Type (Medical Device Analytical Testing Services, Pharmaceutical Analytical Testing Services), By Region, And Segment Forecasts, 2024 - 2030


Healthcare Analytical Testing Services Market Growth & Trends

The global healthcare analytical testing services market size is expected to reach USD 25.47 billion by 2030, expanding at a CAGR of 8.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines’ approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years.

Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expected to offer high growth opportunities to the providers of such services. As pharmaceutical companies across the world have started clinical trials for the development of vaccines therapeutics, and medications for the treatment of COVID-19, the demand for analytical testing has increased. Also, to combat the coronavirus, the growing need to meet the global requirements of medical devices and pharmaceutical products, which must undergo rigorous testing before being distributed to customers, has boosted the production in the industry. This, in turn, is expected to augment the demand for such services.

Healthcare Analytical Testing Services Market Report Highlights
  • The medical device and pharmaceutical market has strict regulations so they are adopting analytical testing services that are driving the market growth.
  • The Pharmaceutical Analytical Testing Services market held the largest market share of 58.3% in 2023.
  • North America dominated the global market with the largest revenue share of 38.49% in 2023 owing to the presence of the largest clinical trials market in the U.S.
  • The Asia Pacific region is anticipated to grow at the fastest CAGR of 8.92% during the forecast period.
  • This growth can be credited to the development and expansion of new facilities in different countries present in this region.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
1.12. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Healthcare Analytical Testing Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis
4.1. Healthcare Analytical Testing Services Market, By Type: Segment Dashboard
4.2. Healthcare Analytical Testing Services Market, By Type: Movement Analysis
4.3. Healthcare Analytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030
4.4. Medical Device Analytical Testing Services
4.4.1. Medical Device Analytical Testing Services Market, 2018 to 2030 (USD Million)
4.4.2. Extractable and Leachable
4.4.2.1. Extractable and Leachable Market, 2018 to 2030 (USD Million)
4.4.3. Material Characterization
4.4.3.1. Material Characterization Market, 2018 to 2030 (USD Million)
4.4.4. Physical Testing
4.4.4.1. Physical Testing Market, 2018 to 2030 (USD Million)
4.4.5. Bioburden Testing
4.4.5.1. Bioburden Testing Market, 2018 to 2030 (USD Million)
4.4.6. Sterility Testing
4.4.6.1. Sterility Testing Market, 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others Market, 2018 to 2030 (USD Million)
4.5. Pharmaceutical Analytical Testing Services
4.5.1. Pharmaceutical Analytical Testing Services Market, 2018 to 2030 (USD Million)
4.5.2. Bioanalytical Testing
4.5.2.1. Bioanalytical Testing Market, 2018 to 2030 (USD Million)
4.5.3. Method Development and Validation
4.5.3.1. Method Development and Validation Market, 2018 to 2030 (USD Million)
4.5.4. Stability Testing
4.5.4.1. Stability Testing Market, 2018 to 2030 (USD Million)
4.5.5. Other Testing Services
4.5.5.1. Other Testing Services Market, 2018 to 2030 (USD Million)
Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. North America
5.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
5.4.2. U.S.
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
5.4.3. Canada
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
5.4.4. Mexico
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
5.5. Europe
5.5.1. UK
5.5.1.1. Key Country Dynamics
5.5.1.2. Competitive Scenario
5.5.1.3. Regulatory Framework
5.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
5.5.2. Germany
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
5.5.3. France
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
5.5.4. Italy
5.5.4.1. Key Country Dynamics
5.5.4.2. Competitive Scenario
5.5.4.3. Regulatory Framework
5.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
5.5.5. Spain
5.5.5.1. Key Country Dynamics
5.5.5.2. Competitive Scenario
5.5.5.3. Regulatory Framework
5.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
5.5.6. Sweden
5.5.6.1. Key Country Dynamics
5.5.6.2. Competitive Scenario
5.5.6.3. Regulatory Framework
5.5.6.4. Sweden Market Estimates and Forecasts, 2018 - 2030
5.5.7. Denmark
5.5.7.1. Key Country Dynamics
5.5.7.2. Competitive Scenario
5.5.7.3. Regulatory Framework
5.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
5.5.8. Norway
5.5.8.1. Key Country Dynamics
5.5.8.2. Competitive Scenario
5.5.8.3. Regulatory Framework
5.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key Country Dynamics
5.6.1.2. Competitive Scenario
5.6.1.3. Regulatory Framework
5.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
5.6.2. China
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. China Market Estimates and Forecasts, 2018 - 2030
5.6.3. India
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. India Market Estimates and Forecasts, 2018 - 2030
5.6.4. Thailand
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. Thailand Market Estimates and Forecasts, 2018 - 2030
5.6.5. South Korea
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
5.6.6. Australia
5.6.6.1. Key Country Dynamics
5.6.6.2. Competitive Scenario
5.6.6.3. Regulatory Framework
5.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key Country Dynamics
5.7.1.2. Competitive Scenario
5.7.1.3. Regulatory Framework
5.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
5.7.2. Argentina
5.7.2.1. Key Country Dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory Framework
5.7.2.4. Argentina Market Estimates and Forecasts, 2018 - 2030
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key Country Dynamics
5.8.1.2. Competitive Scenario
5.8.1.3. Regulatory Framework
5.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
5.8.2. Saudi Arabia
5.8.2.1. Key Country Dynamics
5.8.2.2. Competitive Scenario
5.8.2.3. Regulatory Framework
5.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
5.8.3. UAE
5.8.3.1. Key Country Dynamics
5.8.3.2. Competitive Scenario
5.8.3.3. Regulatory Framework
5.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
5.8.4. Kuwait
5.8.4.1. Key Country Dynamics
5.8.4.2. Competitive Scenario
5.8.4.3. Regulatory Framework
5.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 6. Competitive Landscape
6.1. Market Participant Categorization
6.1.1. Innovators
6.1.2. Market Leaders
6.1.3. Emerging Players
6.1.4. Company Market Share Analysis, 2023
6.2. Company Profiles
6.2.1. PPD, Inc.
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Service Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. ICON plc
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Service Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. LabCorp
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Service Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Charles River Laboratories International, Inc.
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Service Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. Syneos Health
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Service Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. SGS SA
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Service Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Eurofins Scientific
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Service Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Pace Analytical Services, LLC
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Service Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Toxikon, Inc.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Service Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. Intertek Group
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Service Benchmarking
6.2.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings